Malignant Ovarian Mixed Germ Cell Tumor with High-risk Pathology in a Young Woman: Review of Literature

سال انتشار: 1404
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 112

فایل این مقاله در 7 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_JOGCR-10-1_012

تاریخ نمایه سازی: 11 دی 1403

چکیده مقاله:

Background and Aims: Since malignant germ cell tumors (MGCTs) are more frequent in young women, fertility preservation and survival are two main points of management. Here, we introduce a patient with an aggressive MGCT and discuss the fertility preservation in poor prognoses and aggressive tumors. Case Presentation: A ۲۷-year-old G۱L۱ woman was admitted with bilateral ovarian mass, acute pain, and increased tumor markers. Laparotomy revealed multiple large masses. Optimal debulking and staging were performed. In the final pathology, a MGCT (immature teratoma G۲ ۶۰-۷۰% + embryonal carcinoma ۳۰-۴۰%) was reported. The patient returned for chemotherapy after a ۳۵-day gap. Before beginning the chemotherapy, aggressive growth of the tumor and multiple metastases were observed. The patient underwent chemotherapy but the tumor progressed again, and in the MRI performed after chemotherapy, diffuse peritoneal carcinomatosis and tumor growth was observed. Unfortunately, the patient expired. Conclusion: fertility preservation surgery despite optimal debulking is not always associated with a favorable prognosis in high-stage or high-risk patients. In cases of advanced and/or aggressive pathology types (IT, YST, EC), it is logical to consult with the patient and her family to abandon conservative surgery and select more radical surgery.

کلیدواژه ها:

fertility preservation ، Malignant Mixed Tumor ، MGCTs ، Mixed ovarian germ cell tumor

نویسندگان

Maliheh Arab

Department of Gynecology Oncology, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran

Nasim Nouri

Department of Medicine, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Azadeh Jafari Ashtiani

Preventive Gynecology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Behnaz Ghavami

Department of Gynecology Oncology, Arash Women’s Hospital, Tehran University of Medical Sciences, Tehran, Iran

Rezvaneh Sadat Beheshti Rooy

Department of Gynecology Oncology, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran

Masoomeh Raoufi

Department of Radiology, School of Medicine, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Moniaga NC, Randall LM. Malignant mixed ovarian germ cell tumor ...
  • Wang Y, Yang JX, Yu M, Cao DY, Shen K. ...
  • Goyal LD, Kaur B, Badyal RK. Malignant Mixed Germ Cell ...
  • Amirthalingam V, Sharma TD, Rai PC, Singh TT, Devi KP. ...
  • Gaurish SK, Avinash J, Hardas S, Kulkarni MM, Barpande CP. ...
  • Safdar NS, Stall JN, Young RH. Malignant Mixed Germ Cell ...
  • Zhao T, Liu Y, Jiang H, Zhang H, Lu Y. ...
  • Lee Y-L, Lai C-R, Yen M-S. Recurrent ovarian mixed germ ...
  • Shaaban AM, Rezvani M, Elsayes KM, Baskin HJ, Mourad A, ...
  • نمایش کامل مراجع